Sickle cell anaemia: current therapies.
Transfus Apher Sci
; 49(2): 151-4, 2013 Oct.
Article
en En
| MEDLINE
| ID: mdl-23954416
ABSTRACT
Tremendous progress has been made in the treatment of patients with sickle cell anaemia. This paper emphasises the benefit of early therapy with hydroxyurea, the indication for blood transfusions including iron chelation and the role of hematopoietic stem cell transplantation. In order to offer transplantation to a larger number of patients including adolescents and young adults, it is important to find less toxic, but still effective conditioning therapy and to evaluate the feasability of using alternative donors.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Transfusión Sanguínea
/
Quelantes del Hierro
/
Trasplante de Células Madre Hematopoyéticas
/
Hidroxiurea
/
Anemia de Células Falciformes
/
Antidrepanocíticos
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Transfus Apher Sci
Asunto de la revista:
HEMATOLOGIA
Año:
2013
Tipo del documento:
Article